SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-002391
Filing Date
2019-02-13
Accepted
2019-02-13 17:21:59
Documents
65
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1218_relmadatherapeutics.htm 10-Q 387800
2 LEASE AGREEMENT, EFFECTIVE JANUARY 1, 2019, BETWEEN RELMADA THERAPEUTICS, INC. A f10q1218ex10-1_relmadatherap.htm EX-10.1 160536
3 SETTLEMENT AGREEMENT, DATED FEBRUARY 6, 2019, AMONG NAJIB BABUL, LAIDLAW & COMPA f10q1218ex10-2_relmadatherap.htm EX-10.2 93722
4 CONSULTING AGREEMENT, EFFECTIVE MARCH 25, 2019, BETWEEN RELMADA THERAPEUTICS, IN f10q1218ex10-3_relmadatherap.htm EX-10.3 25585
5 CERTIFICATION f10q1218ex31-1_relmadatherap.htm EX-31.1 20107
6 CERTIFICATION f10q1218ex31-2_relmadatherap.htm EX-31.2 20415
7 CERTIFICATION f10q1218ex32-1_relmadatherap.htm EX-32.1 8524
8 CERTIFICATION f10q1218ex32-2_relmadatherap.htm EX-32.2 8233
15 GRAPHIC ex10-1_001.jpg GRAPHIC 1653
  Complete submission text file 0001213900-19-002391.txt   3112371

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE rlmd-20181231.xml EX-101.INS 359087
10 XBRL SCHEMA FILE rlmd-20181231.xsd EX-101.SCH 43101
11 XBRL CALCULATION FILE rlmd-20181231_cal.xml EX-101.CAL 44699
12 XBRL DEFINITION FILE rlmd-20181231_def.xml EX-101.DEF 178551
13 XBRL LABEL FILE rlmd-20181231_lab.xml EX-101.LAB 325425
14 XBRL PRESENTATION FILE rlmd-20181231_pre.xml EX-101.PRE 245974
Mailing Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017 212-547-9591
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55347 | Film No.: 19598762
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1